| Literature DB >> 30418967 |
Jiabao Xu1, Xinghua Su1, Mariangela Bonizzoni2, Daibin Zhong3, Yiji Li1,4, Guofa Zhou3, Hoan Nguyen3, Sarah Tong3, Guiyun Yan1,3, Xiao-Guang Chen1.
Abstract
Wide and improper application of pyrethroid insecticides for mosquito control has resulted in widespread resistance in Aedes albopictus mosquitoes, an important dengue vector. Therefore, understanding the molecular regulation of insecticide resistance is urgently needed to provide a basis for developing novel resistance diagnostic methods and vector control approaches. We investigated the transcriptional profiles of deltamethrin-resistant and -susceptible Ae. albopictus by performing paired-end sequencing for RNA expression analysis. The analysis used 24 independent libraries constructed from 12 wild-caught resistant and 12 susceptible Ae. albopictus female adults. A total of 674,503,592 and 612,512,034 reads were obtained, mapped to the Ae. albopictus genome and assembled into 20,091 Ae. albopictus transcripts. A total of 1,130 significantly differentially expressed genes included 874 up-regulated genes and 256 down-regulated genes in the deltamethrin-resistant individuals. These differentially expressed genes code for cytochrome P450s, cuticle proteins, glutathione S-transferase, serine proteases, heat shock proteins, esterase, and others. We selected three highly differentially expressed candidate genes, CYP6A8 and two genes of unknown function (CCG013931 and CCG000656), to test the association between these 3 genes and deltamethrin resistance using RNAi through microinjection in adult mosquitoes and oral feeding in larval mosquitoes. We found that expression knockdown of these three genes caused significant changes in resistance. Further, we detected 1,162 single nucleotide polymorphisms (SNPs) with a frequency difference of more than 50%. Among them, 5 SNPs in 4 cytochrome P450 gene families were found to be significantly associated with resistance in a genotype-phenotype association study using independent field-collected mosquitoes of known resistance phenotypes. Altogether, a combination of novel individually based transcriptome profiling, RNAi, and genetic association study identified both differentially expressed genes and SNPs associated with pyrethroid resistance in Ae. albopictus mosquitoes, and laid a useful foundation for further studies on insecticide resistance mechanisms.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30418967 PMCID: PMC6258463 DOI: 10.1371/journal.pntd.0006828
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Summary of filtered RNA-seq data for deltamethrin-resistant and -susceptible Aedes albopictus individuals.
| Resistant | Susceptible | |
|---|---|---|
| 12 | 12 | |
| 674,503,592 | 612,512,034 | |
| 56,208,633 | 51,042,670 | |
| 13,126,099 | 11,991,432 | |
| 87,920,874 | 82,427,942 | |
| 36,155,374 | 32,821,820 | |
| 84% (12,632) | 77% (12,759) |
* Gene coverage was calculated as the ratio of the base number a gene covered by unique mapping reads to the total base number of the coding region in the gene. Average gene coverage of 90–100% denotes that 90–100% of a gene was covered by unique mapping reads.
Fig 1Gene Ontology (GO) analysis of differentially expressed genes (DEGs) of Aedes albopictus transcriptome annotated to UniGene cDNA reference data.
Analysis was performed with Blast2GO-PRO. A) Histogram of Ae. albopictus differentially expressed sequences GO classification. Three main ontologies of GO (biological process, cellular component, and molecular function) are shown in the x-axis. The left y-axis indicates the percentage of total genes, and the right y-axis is the number of genes in each category. B) Distribution of transcripts in category of cellular components. C) Distribution of transcripts in category of molecular functions. D) Distribution of transcripts in category of biological processes.
Differentially expressed genes involved in detoxification in deltamethrin resistance and susceptible Aedes albopictus.
| Transcript ID | Chromosome | Region | R FPKM mean | S FPKM mean | R_mean | T-Test | GenBank | Gene name |
|---|---|---|---|---|---|---|---|---|
| lcl|scaffold1478 | complement (165639..167290) | 6.90 | 1.69 | 4.07 | 0.0063 | tca:664295 | ||
| lcl|scaffold5098 | 114116..115695 | 22.49 | 7.26 | 3.10 | 0.0602 | dme:Dmel_CG12800 | ||
| lcl|scaffold3790 | complement (10696..11999) | 1.22 | 0.41 | 2.95 | 0.0154 | tca:655001 | ||
| lcl|scaffold242 | complement (13540..15127) | 0.13 | 0.05 | 2.57 | 0.2129 | dme:Dmel_CG12800 | ||
| lcl|scaffold3898 | 16591..18932 | 7.33 | 3.03 | 2.42 | 0.0294 | dme:Dmel_CG8864 | ||
| lcl|scaffold29929 | 654..1879 | 11.35 | 4.76 | 2.39 | 0.0029 | dme:Dmel_CG3656 | ||
| lcl|scaffold2844_2 | 17180..18196 | 1.94 | 0.85 | 2.28 | 0.1840 | tca:664295 | ||
| lcl|scaffold7278 | complement (5503..7082) | 541.31 | 243.22 | 2.23 | 0.1730 | dme:Dmel_CG9438 | ||
| lcl|scaffold501 | 270699..272928 | 46.34 | 21.00 | 2.21 | 0.0469 | dme:Dmel_CG10248 | ||
| lcl|scaffold17647 | 11732..12808 | 2.84 | 1.31 | 2.18 | 0.0684 | dme:Dmel_CG4373 | ||
| lcl|scaffold4704 | 29466..30259 | 7.78 | 2.09 | 3.72 | 0.2003 | aga:AgaP_AGAP009195 |
R: Resistance, S: Susceptible
Nucleotide polymorphism of genes belonging to metabolic P450 gene family and Glutathione-S-Transferase (GST) significantly expressed between deltamethrin-resistant and -susceptible Ae. albopictus individuals.
| Transcript ID | Gene annotation | Coding region change | Amino acid change | Resistant population | Susceptible population | OR (95%CI) | |||
|---|---|---|---|---|---|---|---|---|---|
| No. homozygote | No. heterozygote | No. homozygote | No. heterozygote | ||||||
| 678A>C | Arg226Ser | 8 | 2 | 2 | 1 | 11.4 (3.0–44.0) | <0.0001 | ||
| 836A>G | Asp279Gly | 9 | 0 | 0 | 1 | 69.0 (7.6–625.9) | <0.0001 | ||
| 740T>C | Ile247Thr | 8 | 0 | 0 | 0 | NA | |||
| 524C>A | Pro175Gln | 7 | 5 | 2 | 1 | 14.4 (3.6–58.2) | <0.0005 | ||
| 2629C>T | His877Tyr | 7 | 3 | 2 | 0 | 12.1 (3.0–48.7) | <0.005 | ||
| 360G>A | Met120Ile | 9 | 0 | 3 | 0 | 9 (2.5–34.7) | <0.005 | ||
| 845T>G | Leu282Arg | 7 | 3 | 2 | 1 | 9.2 (2.5–34.6) | <0.005 | ||
| AGAP009246-PA; cytochrome P450 | 1161A>C | Glu387Asp | 9 | 2 | 4 | 0 | 10 (2.5–39.3) | <0.005 | |
| 634T>A | Cys212Ser | 8 | 3 | 3 | 1 | 9.2 (2.5–34.6) | <0.005 | ||
| 314A>C | Glu105Ala | 11 | 1 | 5 | 1 | 27.2(3.1–235.0) | <0.005 | ||
| 361G>A | Ala121Thr | 6 | 6 | 2 | 1 | 11.4 (3.0–44.0) | <0.005 | ||
| 1328G>A | Arg443Lys | 8 | 2 | 1 | 3 | 11.4 (3.0–44.0) | <0.005 | ||
R: resistant, S: susceptible, NA: not applicable. P: Fisher Exact Probability Test.
a Number of individuals with homozygous SNP genotype. For example, for gene CYP6A8 SNP 678A>C, there were 8 individuals with CC genotype out of the 12 resistant individuals sequenced.
b Number of individuals with heterozygous SNP genotype. For example, for gene CYP6A8 SNP 678A>C, there were 2 individuals with AC genotype out of the 12 resistant individuals sequenced.
Fig 2Comparison of expression value measured by RNA-seq and qRT-PCR.
A) Fold change of expression value in the resistant individuals relative to the susceptible individuals, as measured by RNA-seq and qRT-PCR in 11 selected genes. B) Pearson correlation between fold changes in gene expression between resistant and susceptible mosquitoes, as determined by qRT-PCR and RNA-seq (P<0.05).
Effects of RNAi on the expression of three candidate resistance genes in Aedes albopictus.
Microinjection and oral delivery RNAi were used.
| Microinjection | Oral delivery | |||
|---|---|---|---|---|
| Gene | Control | RNAi | Control | RNAi |
| 1.000 (0.045) | 0.472 (0.063) | 1.000 (0.017) | 0.481 (0.016) | |
| 1.000 (0.079) | 0.337 (0.062) | 1.000 (0.026) | 0.465 (0.057) | |
| 1.000 (0.054) | 0.286 (0.031) | 1.000 (0.004) | 0.520 (0.012) | |
a Control refers to Ae. albopictus Lab-DR strain mosquitoes treated with a siRNA duplex lacking significant sequence homology to any genes in the Ae. aegypti genome.
b RNAi: siRNA-treated group
**, P < 0.01 for comparison between RNAi group and control group.
Association between selected P450 gene SNP frequency and deltamethrin resistance in natural Aedes albopictus populations.
| Gene | Transcript ID | Amino acid change | Phenotype | N | Genotypes | Odds ratio (95%CI) | |||
|---|---|---|---|---|---|---|---|---|---|
| annotation | Homozygous mutation | Heterozygous mutation | Homozygous wild | ||||||
| CCG018947.1 | Arg226Ser | R | 43 | 7 | 6 | 30 | 19.09 (2.49–147) | < 0.0001 | |
| S | 32 | 0 | 1 | 31 | |||||
| Asp279Gly | R | 65 | 5 | 18 | 42 | 1.84 (0.75–4.52) | 0.178 | ||
| S | 27 | 0 | 7 | 20 | |||||
| CCG006037.1 | Pro175Gln | R | 63 | 20 | 11 | 32 | 2.95 (1.43–6.06) | <0.005 | |
| S | 32 | 4 | 4 | 24 | |||||
| CCG006695.1 | His877Tyr | R | 41 | 26 | 9 | 6 | 5.05 (2.38–10.7) | < 0.0001 | |
| S | 26 | 8 | 3 | 15 | |||||
| CCG015439.1 | Met120Ile | R | 51 | 4 | 2 | 45 | 6.85 (0.86–54.8) | 0.037 | |
| S | 32 | 0 | 1 | 31 | |||||
| CCG006036.1 | Leu282Arg | R | 57 | 2 | 3 | 52 | NA | NA | |
| S | 32 | 0 | 0 | 32 | |||||
| CCG011108.1 | Cys212Ser | R | 62 | 55 | 5 | 2 | 55.37 (21.97–140) | <0.0001 | |
| S | 32 | 5 | 2 | 25 | |||||
NA: not applicable. Odds ratio measures the association between SNP genotype and resistance.